The Identification and Characterization of Immunoreactive Fungal Proteins Recognized by Sera from Zimbabweans Sensitized to Fungi.
Fungal allergens
Fungi
SDS-PAGE
Zimbabwe
Journal
International archives of allergy and immunology
ISSN: 1423-0097
Titre abrégé: Int Arch Allergy Immunol
Pays: Switzerland
ID NLM: 9211652
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
02
2022
accepted:
20
04
2022
pubmed:
19
5
2022
medline:
9
9
2022
entrez:
18
5
2022
Statut:
ppublish
Résumé
Exposure to fungal allergens poses a serious threat to human health, especially to mould-allergic individuals. The prevalence of fungal allergic disease is increasing globally but is poorly studied in Africa. Here, we aimed to identify and characterize fungal proteins that were immunoreactive against serum samples from fungal-sensitized Zimbabweans from Shamva district to inform the development of diagnostics and therapeutics. Crude protein extracts of the Ascomycota Aspergillus fumigatus, Alternaria alternata, Cladosporium herbarum, Epicoccum nigrum, Penicillium chrysogenum, and Saccharomyces cerevisiae as well as mucoromycota Rhizopus nigricans were individually separated by one-dimensional gel electrophoresis for protein staining and immunoblotting. A pool of eight sera from fungi-sensitive Zimbabwean children aged 3-5 years was used to screen the crude extracts to determine their immunoreactivity. Protein bands recognized by the sera were subjected to mass spectrometry to identify the individual proteins reactive with the sera. The pooled serum sample reacted with 20 bands, which resolved to 34 distinct proteins, most of which were novel immunogens. The pool was most reactive to A. alternata. The proteins identified included peptidases (8/34), hydrolases (6/34), oxidoreductases (5/34), and glucosidases (4/34), while 11/34 were unknown. Eight of the proteins were predicted to be allergens using the Structural Database of Allergenic Proteins (SDAP). We identified novel immunogens from fungi expanding the number of known fungal allergens. These form a potential basis for diagnostics specific for the Zimbabwean population. Validation assays will now need to be carried out to further evaluate the cross-reactivity of the identified allergen candidates as well as investigate their potential recognition in a larger cohort of patients. Furthermore, there is now a need to conduct studies relating sensitization to these immunogens and clinical diseases in the population.
Sections du résumé
BACKGROUND
Exposure to fungal allergens poses a serious threat to human health, especially to mould-allergic individuals. The prevalence of fungal allergic disease is increasing globally but is poorly studied in Africa. Here, we aimed to identify and characterize fungal proteins that were immunoreactive against serum samples from fungal-sensitized Zimbabweans from Shamva district to inform the development of diagnostics and therapeutics.
METHODS
Crude protein extracts of the Ascomycota Aspergillus fumigatus, Alternaria alternata, Cladosporium herbarum, Epicoccum nigrum, Penicillium chrysogenum, and Saccharomyces cerevisiae as well as mucoromycota Rhizopus nigricans were individually separated by one-dimensional gel electrophoresis for protein staining and immunoblotting. A pool of eight sera from fungi-sensitive Zimbabwean children aged 3-5 years was used to screen the crude extracts to determine their immunoreactivity. Protein bands recognized by the sera were subjected to mass spectrometry to identify the individual proteins reactive with the sera.
RESULTS
The pooled serum sample reacted with 20 bands, which resolved to 34 distinct proteins, most of which were novel immunogens. The pool was most reactive to A. alternata. The proteins identified included peptidases (8/34), hydrolases (6/34), oxidoreductases (5/34), and glucosidases (4/34), while 11/34 were unknown. Eight of the proteins were predicted to be allergens using the Structural Database of Allergenic Proteins (SDAP).
CONCLUSIONS
We identified novel immunogens from fungi expanding the number of known fungal allergens. These form a potential basis for diagnostics specific for the Zimbabwean population. Validation assays will now need to be carried out to further evaluate the cross-reactivity of the identified allergen candidates as well as investigate their potential recognition in a larger cohort of patients. Furthermore, there is now a need to conduct studies relating sensitization to these immunogens and clinical diseases in the population.
Identifiants
pubmed: 35584611
pii: 000524771
doi: 10.1159/000524771
pmc: PMC9533452
doi:
Substances chimiques
Allergens
0
Antigens, Fungal
0
Fungal Proteins
0
Immunoglobulin E
37341-29-0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1007-1016Informations de copyright
© 2022 The Author(s). Published by S. Karger AG, Basel.
Références
Mol Immunol. 2008 Jan;45(2):406-18
pubmed: 17645945
PLoS Pathog. 2021 Apr 29;17(4):e1009503
pubmed: 33914854
Afr Health Sci. 2013 Mar;13(1):144-53
pubmed: 23658581
Mol Genet Genomics. 2007 Jan;277(1):13-22
pubmed: 17077971
Curr Opin Immunol. 2001 Oct;13(5):528-32
pubmed: 11543997
World Allergy Organ J. 2014 May 19;7(1):12
pubmed: 24940476
Med Mycol. 2005 May;43 Suppl 1:S189-96
pubmed: 16110811
World Allergy Organ J. 2013 Oct 03;6(1):17
pubmed: 24090398
FEBS Lett. 1990 Dec 10;276(1-2):172-4
pubmed: 1702393
J Allergy Clin Immunol Pract. 2021 Jan;9(1):82-99
pubmed: 33429724
Am J Ind Med. 2012 Dec;55(12):1110-21
pubmed: 22674665
J Med Vet Mycol. 1992;30(1):11-25
pubmed: 1573519
J Biol Chem. 2006 Jun 16;281(24):16354-60
pubmed: 16608840
Allergy Asthma Immunol Res. 2015 May;7(3):205-20
pubmed: 25840710
Hum Vaccin Immunother. 2017 Oct 3;13(10):2397-2401
pubmed: 28481693
Int Arch Allergy Immunol. 2020;181(4):257-269
pubmed: 32069461
Infect Immun. 1982 Nov;38(2):487-95
pubmed: 6292103
Molecules. 2019 May 31;24(11):
pubmed: 31159327
Mol Plant Microbe Interact. 2007 May;20(5):568-80
pubmed: 17506334
Allergy. 1990 Nov;45(8):577-86
pubmed: 2288393
Curr Res Microb Sci. 2021 Nov 16;2:100082
pubmed: 35028627
Clin Exp Allergy. 1997 May;27(5):584-92
pubmed: 9179435
Mycoses. 2009 Mar;52(2):99-106
pubmed: 18983424
Allergy. 2008 Apr;63(4):454-60
pubmed: 18315733
Proteomics. 2005 Feb;5(3):729-36
pubmed: 15668999
Nucleic Acids Res. 2003 Jan 1;31(1):359-62
pubmed: 12520022
PLoS One. 2015 Aug 28;10(8):e0136258
pubmed: 26317427
Allergy Asthma Immunol Res. 2013 Nov;5(6):348-56
pubmed: 24179680
Infect Immun. 1998 Nov;66(11):5175-82
pubmed: 9784519
Mycopathologia. 2010 Jan;169(1):15-26
pubmed: 19653120
J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):558-62
pubmed: 9802362
S Afr Med J. 2010 Mar 08;100(3):160-3
pubmed: 20459939
Med Mycol. 2021 Sep 03;59(9):923-933
pubmed: 33945622
Microbes Infect. 2000 Jul;2(9):1101-10
pubmed: 10967290
Int Arch Allergy Immunol. 2003 Jan;130(1):2-9
pubmed: 12576728
Immunol Invest. 2005;34(1):37-51
pubmed: 15773571
Clin Exp Allergy. 2007 Aug;37(8):1239-49
pubmed: 17651155
Mol Nutr Food Res. 2017 Aug;61(8):
pubmed: 28191711
Front Biosci. 2003 Jan 01;8:s102-9
pubmed: 12456371
Front Plant Sci. 2017 Sep 05;8:1492
pubmed: 28928754
Immunobiology. 2008;213(1):65-73
pubmed: 18207028
Clin Exp Allergy. 2003 Jan;33(1):22-7
pubmed: 12534545
Nihon Ishinkin Gakkai Zasshi. 2006;47(4):249-55
pubmed: 17086155
Trans R Soc Trop Med Hyg. 2008 Apr;102(4):367-73
pubmed: 18321545
J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):601-7
pubmed: 10482834
Proteomics Clin Appl. 2008 Jan;2(1):33-45
pubmed: 21136777
Int Arch Allergy Appl Immunol. 1988;86(2):201-8
pubmed: 3292441
Clin Med (Lond). 2016 Dec;16(6):584-587
pubmed: 27927826
Allergol Int. 2015 Oct;64(4):321-31
pubmed: 26433528
Clin Exp Allergy. 1995 Dec;25(12):1235-45
pubmed: 8821305
Clin Exp Allergy. 2001 Oct;31(10):1577-82
pubmed: 11678858
J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):396-404
pubmed: 26947460
J Allergy Clin Immunol. 1998 Aug;102(2):256-64
pubmed: 9723670
PLoS Pathog. 2017 May 22;13(5):e1006405
pubmed: 28542620
Mol Immunol. 2009 Apr;46(7):1360-73
pubmed: 19162325
Sci Rep. 2018 Jan 22;8(1):1318
pubmed: 29358620
Pediatr Allergy Immunol. 1995 Nov;6(4):220-2
pubmed: 8822397
mBio. 2010 May 18;1(1):
pubmed: 20689745
Int Arch Allergy Immunol. 2009;150(4):343-51
pubmed: 19571566
World Allergy Organ J. 2014 Aug 19;7(1):22
pubmed: 25152805